A larger study is planned in conjunction with the Center for International Blood and Marrow Transplant Research ( ). The researchers for that study will take an in-depth look at this younger population in an effort to develop a novel risk score for them. Other future efforts will focus on developing interventions to target high risk patients – and in particular, modifiable risk factors – with a focus on preventive measures, he said.
Dr. Friend reported having no financial disclosures.